The Discounted Cash Flow (DCF) valuation of Marinus Pharmaceuticals Inc (MRNS) is (83.64) USD. With the latest stock price at 1.70 USD, the upside of Marinus Pharmaceuticals Inc based on DCF is -5020.1%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.4% - 6.7% | 6.0% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (389.54) - (48.29) | (83.64) |
| Upside | -23014.1% - -2940.7% | -5020.1% |